Search

everythinglearnresearchcommunity

for

Search:↓

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

DM and AA may share a common cause.

Vitamin D helps protect skin, PSORS1 gene's risk interval for psoriasis is expanded, hair follicles can be generated from mouse cells, and interferon-γ may cause pigmented skin lesions.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Mesenchymal stem cells in people with Hidradenitis Suppurativa are more inflammatory, possibly contributing to the disease.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

CGF therapy may effectively treat psoriasis by reducing inflammation.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Tofacitinib is a promising treatment for children with rheumatic diseases.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

New Australian advertising rules improved stem cell marketing practices but further regulation is needed for consumer safety.

Patients in Australia underwent costly, unproven stem cell treatments due to weak regulations and aggressive marketing.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Manage side effects of hepatitis C treatment with dose changes and medications, which may improve patient adherence and treatment success.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Hair gels may cause split ends in children.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.